Verus Financial Partners, Inc. Pfizer Inc Transaction History

Verus Financial Partners, Inc.

$967 Million
Q2 2025

A detailed history of Verus Financial Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 9,292 shares of PFE stock, worth $230,906. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,292

Previous 9,292 -0.0%

Holding current value

$230,906

Previous $235,000 4.26%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$24.8 - $30.19 $5,580 - $6,792	-225 Reduced 2.36%	9,292 $246,000
Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $17,353 - $20,335	-687 Reduced 6.73%	9,517 $266,000
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $20,799 - $27,016	-796 Reduced 7.24%	10,204 $293,000
Q3 2023 Oct 23, 2023	BUY	$32.09 - $37.51 $12,258 - $14,328	382 Added 3.6%	11,000 $364,000
Q2 2023 Jul 27, 2023	SELL	$36.12 - $41.79 $172,834 - $199,965	-4,785 Reduced 31.07%	10,618 $389,000
Q1 2023 May 05, 2023	SELL	$39.39 - $51.28 $24,973 - $32,511	-634 Reduced 3.95%	15,403 $628,000
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $751 - $981	-18 Reduced 0.11%	16,037 $822,000
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $10,852 - $13,248	-248 Reduced 1.52%	16,055 $708,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $30,011 - $35,584	645 Added 4.12%	16,303 $833,000
Q1 2022 Apr 15, 2022	BUY	$45.75 - $56.69 $10,659 - $13,208	233 Added 1.51%	15,658 $832,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $41 - $61	1 Added 0.01%	15,425 $911,000
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $5,966 - $7,663	152 Added 1.0%	15,424 $637,000
Q2 2021 Jul 23, 2021	SELL	$35.91 - $40.68 $10,521 - $11,919	-293 Reduced 1.88%	15,272 $627,000
Q1 2021 Apr 27, 2021	BUY	$33.49 - $37.77 $167 - $188	5 Added 0.03%	15,565 $559,000
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $384,336 - $488,716	-11,483 Reduced 42.46%	15,560 $573,000
Q3 2020 Nov 03, 2020	BUY	$31.75 - $37.25 $385,540 - $452,326	12,143 Added 81.5%	27,043 $992,000
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $572 - $694	-19 Reduced 0.13%	14,900 $487,000
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $4,784 - $6,835	177 Added 1.2%	14,919 $487,000
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $5,859 - $6,650	178 Added 1.22%	14,742 $578,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $162 - $210	-5 Reduced 0.03%	14,564 $523,000
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $145,072 - $162,882	3,923 Added 36.85%	14,569 $631,000
Q1 2019 Apr 19, 2019	BUY	$37.5 - $41.2 $13,200 - $14,502	352 Added 3.42%	10,646 $452,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $34 - $41	1 Added 0.01%	10,294 $454,000
Q2 2018 Jul 16, 2018	BUY	$32.98 - $35.16 $32 - $35	1 Added 0.01%	10,293 $373,000
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $31 - $37	1 Added 0.01%	10,292 $365,000
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $33 - $35	1 Added 0.01%	10,291 $373,000
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $318,990 - $351,403	10,290	10,290 $367,000

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.

Account

Verus Financial Partners, Inc. Pfizer Inc Transaction History